Roles of ERCP in the Early Diagnosis of Pancreatic Cancer

• Main Authors: Keiji Hanada, Tomoyuki Minami, Akinori Shimizu, Motomitsu Fukuhara, Shigeki Yano, Kenji Sasaki, Masanori Koda, Kayo Sugiyama, Shuji Yonehara, Akio Yanagisawa
• Format: Article
• Language: English
• Published: MDPI AG 2019-03-01
• Series: Diagnostics
• Subjects: pancreatic cancer; ERCP; cytology; SPACE; early diagnosis
• Online Access: http://www.mdpi.com/2075-4418/9/1/30

It has been reported that endoscopic retrograde cholangiopancreatography (ERCP) is of value in evaluating precise pancreatograms of the pancreatic duct (PD). Recently, institutions have tended to perform magnetic resonance cholangiopancreatography (MRCP) for the diagnosis of PD due to post-ERCP pancreatitis (PEP). In small pancreatic cancer (PC), including PC in situ (PCIS) which is undetectable on cross sectional images, endoscopic ultrasonography (EUS) and MRCP serve important roles in detecting local irregular stenosis of the PD or small cystic lesions. Subsequently, ERCP and associated serial pancreatic juice aspiration cytologic examination (SPACE) obtained by endoscopic nasopancreatic drainage (ENPD) may be useful in the diagnosis of very early-stage PC. Further prospective multicenter studies are required to establish a standard method of SPACE for the early diagnosis of PC.